FDA Inspection 1043309 — GlaxoSmithKline, LLC.
The FDA completed an inspection of GlaxoSmithKline, LLC. on Jan 26, 2018 in Conshohocken, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Conshohocken, PA (United States)